BriaCell Therapeutics Corp (BCTX) Stock Analysis:
Based on the BriaCell Therapeutics Corp stock forecasts from 1 analysts, the average analyst target price for BriaCell Therapeutics Corp is USD 25.00 over the next 12 months. BriaCell Therapeutics Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of
BriaCell Therapeutics Corp is
Slightly Bullish , which is based on
6 positive signals and
4 negative signals. At the last closing,
BriaCell Therapeutics Corp’s stock price was
USD 4.84.
BriaCell Therapeutics Corp’s stock price has changed by
+2.76% over the past week,
-31.73% over the past month and
+53.65% over the last year.